Homologous Recombination in Protozoan Parasites and Recombinase Inhibitors

Area of Science:

• Molecular Biology
• Genetics
• Parasitology

Background:

• Homologous recombination (HR) is a critical DNA repair pathway essential for maintaining genome stability and genetic diversity.
• HR is conserved in eukaryotes and plays a vital role in protozoan parasites for adaptation and immune evasion.
• Targeting HR presents a potential therapeutic strategy against parasitic infections.

Purpose of the Study:

• To review the current understanding of HR in key protozoan parasites.
• To discuss the potential of small molecule inhibitors targeting HR as therapeutic agents.
• To examine existing inhibitors of human RAD51 for their effects on parasitic HR.

Main Methods:

• Literature review of HR mechanisms in protozoan parasites.
• Analysis of conserved HR pathway components across species.
• Examination of studies on small molecule inhibitors of human RAD51 and their impact on parasitic recombinases.

Main Results:

• HR is essential for survival and genetic adaptation in protozoan parasites like Trypanosoma, Leishmania, Plasmodium, and Entamoeba.
• Small molecule inhibitors targeting human RAD51 have shown effects on Entamoeba recombinases.
• The conserved nature of HR machinery suggests potential for cross-species therapeutic targeting.

Conclusions:

• HR is a crucial and conserved pathway in protozoan parasites, making it a viable therapeutic target.
• Small molecule inhibitors of human RAD51 are promising leads for developing anti-parasitic drugs.
• Further research into HR inhibition could lead to novel treatments for parasitic diseases.